Literature DB >> 2736979

Thrombocytopenia--a rare but potentially serious side effect of initial daily and interrupted use of rifampicin.

C H Lee1, C J Lee.   

Abstract

Thrombocytopenia is occasionally caused by rifampicin, when high-doses are given twice-weekly. This complication is rare when the medication is given in small daily doses, or following a prolonged interruption of therapy. Two cases of rifampicin-induced thrombocytopenia are reported. One occurred within four days of the initiation of small daily doses and the other following a prolonged interruption of therapy.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2736979     DOI： 10.1378/chest.96.1.202

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  5 in total

1.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

2.  Rifampin use and safety in hospitalized infants.

Authors:  Christopher J Arnold; Jessica Ericson; Jordan Kohman; Kaitlyn L Corey; Morgan Oh; Janet Onabanjo; Christoph P Hornik; Reese H Clark; Daniel K Benjamin; P Brian Smith; Vivian H Chu
Journal:  Am J Perinatol       Date:  2015-01-16       Impact factor: 3.079

Review 3.  Monitoring Treatment of Childhood Tuberculosis and the Role of Therapeutic Drug Monitoring.

Authors:  Andrea T Cruz; Jeffrey R Starke
Journal:  Indian J Pediatr       Date:  2019-02-28       Impact factor: 5.319

4.  Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.

Authors:  P Brian Smith; C Michael Cotten; Mark L Hudak; Janice E Sullivan; Brenda B Poindexter; Michael Cohen-Wolkowiez; Felix Boakye-Agyeman; Andrew Lewandowski; Ravinder Anand; Daniel K Benjamin; Matthew M Laughon
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.938

5.  Isoniazid-induced Immune Thrombocytopenia.

Authors:  Gaku Kuwabara; Kumiyo Tazoe; Waki Imoto; Kazushi Yamairi; Wataru Shibata; Kazuhiro Oshima; Koichi Yamada; Yasuhiro Takagi; Satoshi Shiraishi; Masayuki Hino; Tomoya Kawaguchi; Hiroshi Kakeya
Journal:  Intern Med       Date:  2021-05-29       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.